Taxapharm SRL
0.4 FTETaxapharm reported total assets of 35,480 € at the end of the 2025 financial year (annual accounts filed with the NBB on 14 Aug 2026), with 0.4 full-time equivalent.
The score of Taxapharm shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Total assets -73 % Headcount (avg FTE) -64 %
Accounts of the company itself (not consolidated).
The full file covers 19 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Taxapharm's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | −64,664 € | ||||
| Equity | −446,038 € | ||||
| Cash | 1,448 € | ||||
| EBITDA | −54,772 € | ||||
| Total assets | 35,480 € |
Filed annual accounts
- Year ended 31 Dec 2025filed on 14 Aug 2026
- Year ended 31 Dec 2024filed on 29 Aug 2025
- Year ended 31 Dec 2023filed on 28 Aug 2024
- Year ended 31 Dec 2022filed on 30 Aug 2023
- Year ended 31 Dec 2021filed on 29 Aug 2022
Taxapharm's financial analysis
- Solvency-1257.2%sector median: 41.5%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Taxapharm
Taxapharm's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0879.817.912
- VAT number
- BE0879817912
- Peppol
- Registered · 0208:0879817912 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 08 Mar 2006
- Registered office
- 1410 Waterloo
- Size
- Micro · 0.4 FTE
- Latest accounts
- 2025 · filed on 14 Aug 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Taxapharm (SRL) has been based in Waterloo since 2006, active in: retail sale of pharmaceutical products. For 2025, it reports a net loss of 64,664 € and equity of −446,038 €; its revenue is not published. With 0.4 full-time equivalents, it is a micro-enterprise by headcount. Its solvency stands at -1257.2%, below the median of its sector (41.5%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Taxapharm
Companies in the same business, of comparable size and area, outside its group.
- Pharmacie Pharmiste Retail sale of pharmaceutical products Brussels · balance sheet 57,475 €
- Pharmavanty Retail sale of pharmaceutical products Ninove · balance sheet 34,846 €
- Apotheker Silke Christiaens Retail sale of pharmaceutical products Lennik · balance sheet 37,111 €
- NL Pharma Retail sale of pharmaceutical products Florennes · balance sheet 33,758 €
- PharmAzzy Retail sale of pharmaceutical products Zonhoven · balance sheet 37,787 €
- VENI Retail sale of pharmaceutical products Meise · balance sheet 32,367 €
- Lorena Boulanger Pharma Retail sale of pharmaceutical products Chapelle-lez-Herlaimont · balance sheet 32,165 €
- Goed Aalter Retail sale of pharmaceutical products Anderlecht · balance sheet 31,881 €
Frequently asked questions about Taxapharm
What is the revenue of Taxapharm?
Taxapharm files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Taxapharm?
In Belgium, the VAT number is the company number prefixed with BE: BE0879817912 for Taxapharm, if the company is VAT-registered. Its company number (CBE) is 0879.817.912.
Where is the registered office of Taxapharm?
According to the CBE register, the registered office of Taxapharm is in 1410 Waterloo.
What is the equity of Taxapharm?
At the close of the 2025 financial year, the equity of Taxapharm amounts to -446,038 €, a solvency of -1257.2% of total assets.
How many people work at Taxapharm?
0.4 full-time equivalents on average according to the 2025 social balance sheet.
Who manages Taxapharm?
The register lists 2 active mandates at Taxapharm. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Taxapharm
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →